Ruiz-Camps, I., & Aguilar-Company, J. (2021). Risk of infection associated with targeted therapies for solid organ and hematological malignancies. Ther Adv Infect Dis.
Chicago-stil citatRuiz-Camps, Isabel, och Juan Aguilar-Company. "Risk of Infection Associated With Targeted Therapies for Solid Organ and Hematological Malignancies." Ther Adv Infect Dis 2021.
MLA-referensRuiz-Camps, Isabel, och Juan Aguilar-Company. "Risk of Infection Associated With Targeted Therapies for Solid Organ and Hematological Malignancies." Ther Adv Infect Dis 2021.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.